Studies have shown that glycyrrhizenic acid is produced by adjusting autophagy and inhibiting the PI3K/AKT/mTOR pathway after induction by inflammatory factors in ALI, which can provide new therapies for Ali GA (Qu et al., 2019). Here, AKT1 is linked to acute respiratory distress syndrome.